iRhythm (IRTC) executive granted 10,034 RSUs in new equity award

2026-03-17 07:13:08

Minang Turakhia, Chief Medical and Scientific Officer and EVP of Advanced Technology at iRhythm Holdings, Inc. (IRTC), was granted 10,034 Restricted Stock Units (RSUs) as a new equity award on February 25, 2026. These RSUs vest 25% on March 1, 2027, with the remainder vesting annually thereafter, contingent on his continued employment. Following this grant, Turakhia directly holds 58,933 shares of iRhythm common stock.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.